| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |